Dilip & Anand Surana

Siblings who inherited generics firm Micro Labs from their father faced a rough patch as the U.S. Food & Drug Administration issued a warning letter to their Bangalore factory over quality concerns. Earlier this year the firm recalled an anticholesterol drug. In September the firm launched a pill that increases the platelet count in patients being treated for dengue fever.